financetom
Business
financetom
/
Business
/
Beigene Insider Sold Shares Worth $7,805,106, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Beigene Insider Sold Shares Worth $7,805,106, According to a Recent SEC Filing
Dec 12, 2024 2:46 PM

05:22 PM EST, 12/12/2024 (MT Newswires) -- Xiaodong Wang, Director, Chair, Scientific Advisory Board, on December 10, 2024, sold 41,760 shares in Beigene ( BGNE ) for $7,805,106. Following the Form 4 filing with the SEC, Wang has control over a total of 10,324,993 shares of the company, with 5,240,882 shares held directly and 5,084,111 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1651308/000165130824000166/xslF345X05/wk-form4_1734041881.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Inseego Completes $52 Million Sale of Telematics Business to Ctrack
Inseego Completes $52 Million Sale of Telematics Business to Ctrack
Dec 2, 2024
10:14 AM EST, 12/02/2024 (MT Newswires) -- Inseego ( INSG ) said Monday that it has completed the sale of its global telematics business to Convergence Partners' portfolio company Ctrack Holdings for $52 million in cash. The company said the sale is intended to improve its focus on its core 5G domestic business and raise funds for recapitalization and debt...
Delcath Gets FDA Clearance for Phase 2 Liver Cancer Trial
Delcath Gets FDA Clearance for Phase 2 Liver Cancer Trial
Dec 2, 2024
10:17 AM EST, 12/02/2024 (MT Newswires) -- Delcath Systems ( DCTH ) said Monday that the US Food and Drug Administration cleared its investigational new drug application for a phase 2 clinical trial of Hapzato, in combination with standard of care, in liver-dominant metastatic colorectal cancer. The trial will evaluate the safety and efficacy of the combination therapy, with a...
Bumble CFO to step down next year amid growth challenges
Bumble CFO to step down next year amid growth challenges
Dec 2, 2024
Dec 2 (Reuters) - Bumble said on Monday Anu Subramanian will step down as chief financial officer, effective March 14, 2025. Subramanian, who joined the dating app operator as CFO in 2020, played a key role in the company's initial public offering in 2021. Bumble has begun searching for Subramanian's successor. Shares of the company fell 1.7% in early morning...
NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
Dec 2, 2024
On Monday, NovoCure Ltd ( NVCR ) and Zai Lab Limited ( ZLAB ) revealed topline data from the Phase 3 PANOVA-3 trial of Tumor-Treating Fields (TTFields) therapy concomitantly with gemcitabine and nab-paclitaxel as a first-line treatment for unresectable, locally advanced pancreatic adenocarcinoma. The pivotal trial met its primary endpoint, demonstrating a statistically significant improvement in median overall survival (mOS) versus...
Copyright 2023-2026 - www.financetom.com All Rights Reserved